Dentons US LLP
Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia
Provided are compositions and formulations or co-formulations containing a hyaluronan degrading enzyme. The compositions, formulations or co-formulations can also contain another therapeutic agent, such as one that is suitable for treatment of Benign Prostatic Hyperplasia, for example, a 5-alpha reductase inhibitor. The compositions and formulations can be used for the treatment of Benign Prostatic Hyperplasia. The compositions and formulations can be provided in combinations with one or more other agents for the treatment of Benign Prostatic Hyperplasia.
Halozyme, Inc.
A A A A A A
A61P A61K A61P A61P A61K A61K
inventional inventional inventional inventional inventional inventional
Louis Howard Mysore Gregory Ian Curtis Xiaoming Harold Michael
Bookbinder Ramprasad Frost Thompson Li Shepard